Investment logic
We define the problem, user, available data, risk and measurable result before selecting technology.
NPNT · AI and digital systems for biotechnology
AI systems for biotech, medicine and production
We help biotechnology leaders and investors turn an industry problem into a verifiable digital product—from architecture and pilot to implementation and support.
27 projectsResident of Sirius INTC
About NPNT
From an investment thesis to an operating system
NPNT connects domain expertise, product architecture and engineering execution. Every first stage has a bounded environment and a continuation criterion.
Flagship development
Four systems defining NPNT’s next stage
We show operating structures, their current stage and the next verifiable step—not showcase promises.
View all projects →01Product / initiative
Medical AI · исследовательская инфраструктура
Clinical Trial Digital Ecosystem
A shared environment for patients, investigators, coordinators, sponsors and research sites.
Practical contribution
Creates a more transparent clinical-research workflow across protocol, communication, site status and quality.
02Digital project
Этическая экспертиза · документы · процессный контроль
LEC Workspace · LEC AI
Digital support for ethics review: document versions, deadlines, meetings, conflicts of interest, reports and modules for experts and research teams. NPNT is developing the project together with Yandex.
Practical contribution
Turns fragmented emails and files into a traceable ethics-review workflow while authorised committee members retain the decision.
03Product / initiative
Промышленный AI · биотех · фарма · foodtech
PROMCYCLE AI
A platform for applying AI to biotech, pharma, cosmetics and food production—from line data to a controlled pilot.
Practical contribution
Helps leaders locate process losses, define an AI-assisted action and prove value with an agreed KPI.
04Product / initiative
Навигация пациентов · клинические исследования
MIKA.help
An information-navigation platform helping people with cancer find clinical trials and prepare the next route towards a research centre since 2016.
Practical contribution
Reduces the information gap between a complex protocol and a safe next step while professionals retain decisions.
NPNT news
What is happening across the projects
Real stages, clearly labelled: expert review, hypothesis testing, bounded pilots and the next validation criteria.
NAIIO: platform testing remains in a closed environment
naiio.org currently presents a “Closed site preview” page. It asks for a password provided to the association’s founders and experts, and says access is for internal discussion; the materials are not yet a public version of the Association’s documents. NPNT’s portfolio describes NAIIO as a platform for the National Association of Researchers and Research Organizations, built on professional social-network principles. Its stated stage is “In development and testing”; the portfolio says a closed version has been prepared in Russian, English, Chinese and Hindi. Because the site is password-protected, profile and network functions cannot be checked without authorized access. A restricted preview allows participants to discuss materials before public presentation. It does not by itself confirm that the Association has launched, or verify membership or accreditation of people and organizations. The platform’s practical value, profile-verification quality and ability to support professional collaboration require separate evidence; these outcomes cannot be inferred from the public access page.
Read update →Two Paths: prevention starts with choosing a scenario
The Two Paths website presents an 18+ age confirmation before its materials. Its notice says the site contains educational content about dependencies, illness, violence and other dangerous life situations. NPNT’s portfolio describes the project as a story about two possible life scenarios—with or without tobacco—and the possibility of changing course. It is a published social and educational project; the public landing page currently shows an age screen before continuing. This format may provide a prompt for discussing the consequences of choices and available support. It is not medical advice, does not assess an individual’s condition and does not promise to change behaviour. The project also does not replace a doctor or specialist support for stopping tobacco use. The accessibility and usefulness of the materials after age confirmation, how different audiences understand them, and any effect on visitor decisions require separate evaluation. These outcomes cannot be established from the public landing page alone.
Read update →AI / Science: a demo route from hypothesis to expert review
AI / Science presents a conceptual demo for research: a route from a hypothesis to expert review. Demo text is not sent to a server. The public page shows four steps: an evidence map, design options for an observational study, sample-size scenarios, and a document package. It explicitly says this is an interface demonstration, not a scientific recommendation. A separate preliminary-review flow for ethics committee materials describes checks for completeness, consistency, ethical questions, and explainable comments linked to document passages. The concept aims to connect research preparation in a clear route and make comments traceable for researchers and reviewers. AI can suggest options and surface questions; decisions about design, ethics, and clinical appropriateness remain with qualified specialists and the committee. The public version is a conceptual demo environment. The page does not establish deployment, clinical validation, or achieved performance. The accuracy of suggestions, quality of sources, and any effect on timelines or research quality require separate evaluation in a real process.
Read update →A bounded first stage
Describe the problem—we will outline the architecture of the first step
An initial assessment does not require medical records, trade secrets or a data dump. Process context and the intended outcome are enough.
- 01The process, product or audience that needs to change
- 02The data or materials already available
- 03Who owns the decision and which criterion will define success
Our first reply will clarify the process, available data, accountable specialist and success criterion. We will then propose a bounded first stage with an indicative timeline and budget.
Describe the problem →